Pre-clinical drug-drug interaction (DDI) of gefitinib or erlotinib with Cytochrome P450 (CYP) inhibiting drugs, fluoxetine and/or losartan
- Resource Type
- Article
- Source
- In
Current Research in Toxicology 2021 2:217-224 - Subject
- Language
- ISSN
- 2666-027X